Oncolytics Biotech, Inc. (ONCY)
0.85
+0.01
(+0.82%)
USD |
NASDAQ |
Aug 24, 16:00
0.85
0.00 (0.00%)
After-Hours: 20:00
Oncolytics Biotech Shareholders Equity (Quarterly) : -6.167M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.167M |
| March 31, 2026 | -5.13M |
| December 31, 2025 | -3.799M |
| September 30, 2025 | -0.272M |
| June 30, 2025 | 3.699M |
| March 31, 2025 | 4.512M |
| December 31, 2024 | 3.298M |
| September 30, 2024 | 6.704M |
| June 30, 2024 | 13.38M |
| March 31, 2024 | 16.97M |
| December 31, 2023 | 20.90M |
| September 30, 2023 | 21.46M |
| June 30, 2023 | 16.81M |
| March 31, 2023 | 19.03M |
| December 31, 2022 | 19.56M |
| September 30, 2022 | 20.67M |
| June 30, 2022 | 23.86M |
| March 31, 2022 | 28.03M |
| December 31, 2021 | 28.58M |
| September 30, 2021 | 33.72M |
| June 30, 2021 | 37.54M |
| March 31, 2021 | 35.54M |
| December 31, 2020 | 19.43M |
| September 30, 2020 | 15.70M |
| June 30, 2020 | 17.61M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.46M |
| December 31, 2019 | -0.0832M |
| September 30, 2019 | 2.607M |
| June 30, 2019 | 2.899M |
| March 31, 2019 | 4.267M |
| December 31, 2018 | 4.536M |
| September 30, 2018 | 7.001M |
| June 30, 2018 | 8.337M |
| March 31, 2018 | 3.679M |
| December 31, 2017 | 6.612M |
| September 30, 2017 | 9.648M |
| June 30, 2017 | 10.99M |
| March 31, 2017 | 5.455M |
| December 31, 2016 | 7.971M |
| September 30, 2016 | 11.89M |
| June 30, 2016 | 14.31M |
| March 31, 2016 | 15.82M |
| December 31, 2015 | 17.76M |
| September 30, 2015 | 20.68M |
| June 30, 2015 | 24.13M |
| March 31, 2015 | 21.45M |
| December 31, 2014 | 11.93M |
| September 30, 2014 | 13.23M |
| June 30, 2014 | 15.38M |
| March 31, 2014 | 16.49M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
| Vicapsys Life Sciences, Inc. | -3.549M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.671M |
| Total Liabilities (Quarterly) | 13.84M |
| Debt to Equity Ratio | -0.0726 |
| Current Ratio | 1.353 |
| Net Debt Paydown Yield | 0.04% |